Paper Details

  1. Home
  2. Paper Details

[Valganciclovir. Oral treatment of Cytomegalovirus infections].

Author: KroesA C M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Valganciclovir is an oral prodrug of ganciclovir, an effective drug for treating cytomegalovirus infections. Its good bioavailability and rapid conversion to ganciclovir make it a viable alternative to intravenous ganciclovir. Valganciclovir is currently approved for treating cytomegalovirus retinitis in AIDS patients and preventing cytomegalovirus disease after organ transplantation. Further applications in pre-emptive treatment and prophylaxis are being explored.
Paper Details　
Original Abstract of the Article :
Valganciclovir is an orally administered prodrug of ganciclovir, the most widely used drug in the clinical management of Cytomegalovirus infections. The good bioavailability and the rapid conversion into ganciclovir provide oral valganciclovir with pharmacokinetic properties approaching those of int...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15301386

データ提供：米国国立医学図書館（NLM）

Valganciclovir: A New Weapon in the Fight Against Cytomegalovirus

Cytomegalovirus (CMV) infections can be a real challenge, like trying to navigate a desert filled with sandstorms. Valganciclovir is a new drug that offers a much-needed respite from the discomfort and complications of CMV infections. This study explores the effectiveness of valganciclovir in treating CMV retinitis in AIDS patients and preventing CMV disease after organ transplantation. Valganciclovir is a prodrug of ganciclovir, which is like a camel caravan carrying essential supplies. It offers a convenient oral administration with excellent bioavailability and rapid conversion into ganciclovir.

A New Route Through the Desert: Valganciclovir for CMV Infections

This study shows that valganciclovir is an effective treatment for CMV retinitis in AIDS patients and can prevent CMV disease after organ transplantation. It's like finding a new, smoother road through the desert, making the journey less treacherous and more manageable.

Staying Ahead of the Sandstorms: Preventing CMV Infections with Valganciclovir

Valganciclovir offers a promising new approach to treating and preventing CMV infections. It's like having a reliable map and a sturdy camel – tools that can help us navigate the desert and stay safe.

Dr.Camel's Conclusion

This research highlights the effectiveness and convenience of valganciclovir in treating and preventing CMV infections. This drug is a valuable tool in the fight against CMV, offering a new path through the desert of viral infections.

Date :
  1. Date Completed 2004-09-02
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

15301386

DOI: Digital Object Identifier

15301386

SNS
PICO Info
in preparation
Languages

Dutch

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.